Literature DB >> 23534914

Distribution and factors associated with four premature ejaculation syndromes in outpatients complaining of ejaculating prematurely.

Xiansheng Zhang1, Jingjing Gao, Jishuang Liu, Lei Xia, Jiajia Yang, Zongyao Hao, Jun Zhou, Chaozhao Liang.   

Abstract

INTRODUCTION: Because available definitions of premature ejaculation (PE) were unable to encompass the various forms of PE, Waldinger et al. proposed a new classification that distinguished four PE syndromes. However, few studies have examined the prevalence rates of these four PE syndromes. AIMS: The study aims to analyze the prevalence of and factors associated with four PE syndromes in outpatients who complained of ejaculating prematurely.
METHODS: Between December 2009 and December 2011, outpatients who complained of PE completed a detailed verbal questionnaire regarding their demographic data and medical and sexual history. Each patient was classified as having one of four PE subtypes: lifelong PE (LPE), acquired PE (APE), natural variable PE (NVPE), or premature-like ejaculatory dysfunction (PLED). MAIN OUTCOME MEASURES: Based on the new classification scheme, PE was classified into four subtypes. The anxiety/depression status of patients was assessed by the Zung self-rating anxiety/depression scales, and erectile function was assessed by the International Index of Erectile Function-5 instrument.
RESULTS: This study included 1,988 male outpatients who complained of PE, with mean ages and body mass index (BMI) scores of 35.52 ± 10.38 years and 25.34 ± 4.51 kg/m(2), respectively. Prevalence rates of PE syndromes were 35.66% for LPE, 28.07% for APE, 12.73% for NVPE, and 23.54% for PLED. Patients with APE had the highest mean ages and BMI scores, and they more frequently reported several comorbidities, including sexual desire disorder, hypertension, diabetes mellitus, chronic prostatitis, and erectile dysfunction. The PLED group had a lower mean frequency of sexual intercourse than other groups and higher rates of anxiety and depression.
CONCLUSION: The prevalence of LPE was higher than that of other PE subtypes in an outpatient setting. Several comorbidities were more common in patients with APE and PLED. In particular, a lower frequency of intercourse and higher frequencies of anxiety and depression were found in patients with PLED.
© 2013 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2013        PMID: 23534914     DOI: 10.1111/jsm.12123

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  21 in total

Review 1.  Advances in understanding and treating premature ejaculation.

Authors:  Theodore R Saitz; Ege Can Serefoglu
Journal:  Nat Rev Urol       Date:  2015-10-27       Impact factor: 14.432

2.  The association of anxiety with the subtypes of premature ejaculation: a chart review.

Authors:  Ravi Philip Rajkumar; Arun Kumar Kumaran
Journal:  Prim Care Companion CNS Disord       Date:  2014-07-31

3.  Prevalence of prostatitis-like symptoms in outpatients with four premature ejaculation syndromes: a study in 438 men complaining of ejaculating prematurely.

Authors:  Dongdong Tang; Xiansheng Zhang; Zongyao Hao; Jun Zhou; Chaozhao Liang
Journal:  Int J Clin Exp Med       Date:  2014-07-15

4.  The relationship between acquired premature ejaculation and metabolic syndrome: a prospective, comparative study.

Authors:  D Bolat; G U Kocabas; B Gunlusoy; O Aydogdu; M E Aydin
Journal:  Int J Impot Res       Date:  2017-02-09       Impact factor: 2.896

5.  Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism.

Authors:  A M Salem; I I Kamel; L A Rashed; S F GamalEl Din
Journal:  Int J Impot Res       Date:  2016-09-29       Impact factor: 2.896

Review 6.  An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation.

Authors:  Ege Can Serefoglu; Chris G McMahon; Marcel D Waldinger; Stanley E Althof; Alan Shindel; Ganesh Adaikan; Edgardo F Becher; John Dean; Francois Giuliano; Wayne Jg Hellstrom; Annamaria Giraldi; Sidney Glina; Luca Incrocci; Emmanuele Jannini; Marita McCabe; Sharon Parish; David Rowland; R Taylor Segraves; Ira Sharlip; Luiz Otavio Torres
Journal:  Sex Med       Date:  2014-06       Impact factor: 2.491

Review 7.  An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE).

Authors:  Stanley E Althof; Chris G McMahon; Marcel D Waldinger; Ege Can Serefoglu; Alan W Shindel; P Ganesan Adaikan; Edgardo Becher; John Dean; Francois Giuliano; Wayne Jg Hellstrom; Annamaria Giraldi; Sidney Glina; Luca Incrocci; Emmanuele Jannini; Marita McCabe; Sharon Parish; David Rowland; R Taylor Segraves; Ira Sharlip; Luiz Otavio Torres
Journal:  Sex Med       Date:  2014-06       Impact factor: 2.491

Review 8.  Advances in treating premature ejaculation.

Authors:  Selahittin Cayan; Ege Can Serefoğlu
Journal:  F1000Prime Rep       Date:  2014-07-08

9.  Measurement errors in polymerase chain reaction are a confounding factor for a correct interpretation of 5-HTTLPR polymorphism effects on lifelong premature ejaculation: a critical analysis of a previously published meta-analysis of six studies.

Authors:  Paddy K C Janssen; Berend Olivier; Aeilko H Zwinderman; Marcel D Waldinger
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

Review 10.  The design and methodology of premature ejaculation interventional studies.

Authors:  Chris G McMahon
Journal:  Transl Androl Urol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.